Although our study did not directly assess risk factors for development of ARR, our findings are consistent with other reports of ARR being associated with HIV infection, initial resistance to isoniazid, low CD4 counts, and intermittent TB therapy during the continuation phase [3], [15], [19], [20]. This evidence concerns the gene CD4 and HIV infectious disease.